跳至主要内容
临床试验/NCT01234155
NCT01234155已完成不适用

Exercise Training and Type 2 Diabetes

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Glycemic Control

研究概览

简要总结

The purpose of this study is to assess whether 4-months of interval-walking exercise training improves glycemic control in individuals with type 2 diabetes mellitus. The effects of interval-walking training will be compared to continuous-walking exercise in a randomised, controlled trial design. Changes in glycemic control will be examined using oral glucose tolerance tests (OGTT) with stable isotope methodology. In addition, insulin sensitivity and secretion will be examined using glucose clamps combined with glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 to 80
  • normal glucose tolerance, impaired glucose tolerance, or type 2 diabetes (as evidenced by use of oral hypoglycemic medication or 2-hour OGTT glucose > 11.1 mmol/l)

排除标准

  • Insulin treatment or type 1 diabetes
  • BMI <19 or >40
  • Physically active
  • Undergoing weight-loss/gain
  • Pregnancy
  • Contraindication to exercise (ECG/CPX)
  • Significant cardiovascular disease
  • History of renal/hepatic/gastrointestinal/pulmonary disease
  • Clotting or bleeding disorders

结局指标

主要结局

Glycemic Control

时间窗: 0 and 4 months

Fasting glucose, two-hour glucose during OGTT, and hemoglobin A1c will be measured.

次要结局

  • Beta-cell Function(0 and 4 months)
  • Body Composition(0 and 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Solomon

Group Leader

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验